Moncef Slaoui – Pandemic Timeline https://pandemictimeline.com Chronological Sequence of Events Tue, 19 Mar 2024 04:03:42 +0000 en-US hourly 1 https://wordpress.org/?v=6.7.2 https://pandemictimeline.com/wp-content/uploads/2021/06/Covid-150x150.ico Moncef Slaoui – Pandemic Timeline https://pandemictimeline.com 32 32 Pres. Trump announces Operation Warp Speed https://pandemictimeline.com/2020/05/pres-trump-announces-operation-warp-speed/ Fri, 15 May 2020 00:00:02 +0000 https://pandemictimeline.com/?p=2164 Operation Warp Speed (OWS) was a public–private partnership initiated by the United States government to facilitate and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. Moncef Slaoui and Gen. Gustave Perna were named as leads for Operation Warp Speed. Pres. Trump has always emphasized that acceptance of the vaccines is voluntary.  They are not to…

]]>

Operation Warp Speed (OWS) was a public–private partnership initiated by the United States government to facilitate and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.

Moncef Slaoui and Gen. Gustave Perna were named as leads for Operation Warp Speed.

OWS ORG CHART AO 1300 30 JUL 2020

Pres. Trump has always emphasized that acceptance of the vaccines is voluntary.  They are not to be mandated.

Sources:

See also, on this site:

]]>
Moncef Slaoui Departs Galvani Bioelectronics Board of Directors https://pandemictimeline.com/2023/03/moncef-slaoui-departs-galvani-bioelectronics-board-of-directors/ Mon, 27 Mar 2023 22:18:17 +0000 https://pandemictimeline.com/?p=13205 The Board of Directors of GlaxoSmithKline plc (“GSK”), the majority shareholder of Galvani Bioelectronics (“Galvani”), today announced the termination of Moncef Slaoui as Chair of the Galvani Board of Directors, effective immediately. The termination follows the receipt of a letter containing allegations of sexual harassment and inappropriate conduct towards an employee of GSK by Dr.…

]]>

The Board of Directors of GlaxoSmithKline plc (“GSK”), the majority shareholder of Galvani Bioelectronics (“Galvani”), today announced the termination of Moncef Slaoui as Chair of the Galvani Board of Directors, effective immediately.

The termination follows the receipt of a letter containing allegations of sexual harassment and inappropriate conduct towards an employee of GSK by Dr. Slaoui, which occurred several years ago when he was an employee of GSK.

GSK

Sources:

]]>